bb3497 has been researched along with amikacin in 1 studies
Studies (bb3497) | Trials (bb3497) | Recent Studies (post-2010) (bb3497) | Studies (amikacin) | Trials (amikacin) | Recent Studies (post-2010) (amikacin) |
---|---|---|---|---|---|
13 | 0 | 2 | 4,739 | 485 | 1,316 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Canaan, S; Cavalier, JF; Magrioti, V; Mallick, I; Mavrikaki, V; Pagonis, A; Poncin, I | 1 |
1 other study(ies) available for bb3497 and amikacin
Article | Year |
---|---|
Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
Topics: Animals; Anti-Bacterial Agents; Hydrazines; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship | 2022 |